大葉大學圖書館 |

Colitis-associated cancer[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.994347
書名/作者:	Colitis-associated cancer/ edited by Masato Kusunoki.
其他作者:	Kusunoki, Masato.
出版者:	Tokyo : : Springer Japan :, 2016.
面頁冊數:	viii, 150 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Inflammatory bowel diseases.
標題:	Ulcerative colitis.
標題:	Crohn's disease.
標題:	Rectum - Cancer.
標題:	Colon (Anatomy) - Cancer.
標題:	Medicine & Public Health.
標題:	Surgery.
標題:	Surgical Oncology.
標題:	Cancer Research.
標題:	Gene Function.
ISBN:	9784431555223
ISBN:	9784431555216
內容註:	Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease.
摘要、提要註:	As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
電子資源:	http://dx.doi.org/10.1007/978-4-431-55522-3

Colitis-associated cancer[electronic resource] /
Colitis-associated cancer[electronic resource] /edited by Masato Kusunoki. - Tokyo :Springer Japan :2016. - viii, 150 p. :ill., digital ;24 cm.

Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease.

As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.

ISBN: 9784431555223

Standard No.: 10.1007/978-4-431-55522-3doiSubjects--Topical Terms:

341436
Inflammatory bowel diseases.

LC Class. No.: RC280.C6

Dewey Class. No.: 616.994347

Colitis-associated cancer[electronic resource] /
LDR:02500nam a2200313 a 4500 001 455231
003 DE-He213
005 20160727151304.0
006 m d
007 cr nn 008maaau
008 161227s2016 ja s 0 eng d
020 $a 9784431555223 $q (electronic bk.)
020 $a 9784431555216 $q (paper)
024 7 $a 10.1007/978-4-431-55522-3 $2 doi
035 $a 978-4-431-55522-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.C6
072 7 $a MN $2 bicssc
072 7 $a MED085000 $2 bisacsh
082 0 4 $a 616.994347 $2 23
090 $a RC280.C6 $b C696 2016
245 0 0 $a Colitis-associated cancer $h [electronic resource] / $c edited by Masato Kusunoki.
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a viii, 150 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease.
520 $a As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
650 0 $a Inflammatory bowel diseases. $3 341436
650 0 $a Ulcerative colitis. $3 456114
650 0 $a Crohn's disease. $3 604814
650 0 $a Rectum $x Cancer. $3 496252
650 0 $a Colon (Anatomy) $x Cancer. $3 496251
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Surgery. $3 405843
650 2 4 $a Surgical Oncology. $3 465555
650 2 4 $a Cancer Research. $3 463530
650 2 4 $a Gene Function. $3 463605
700 1 $a Kusunoki, Masato. $3 653413
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55522-3
950 $a Medicine (Springer-11650)